Larimar Therapeutics (LRMR) Research & Development (2016 - 2019)
Historic Research & Development for Larimar Therapeutics (LRMR) over the last 6 years, with Q4 2019 value amounting to $423000.0.
- Larimar Therapeutics' Research & Development fell 9630.79% to $423000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $23.9 million, marking a year-over-year decrease of 5016.38%. This contributed to the annual value of $23.9 million for FY2019, which is 5016.38% down from last year.
- Larimar Therapeutics' Research & Development amounted to $423000.0 in Q4 2019, which was down 9630.79% from $5.3 million recorded in Q3 2019.
- Larimar Therapeutics' 5-year Research & Development high stood at $17.7 million for Q4 2015, and its period low was $423000.0 during Q4 2019.
- In the last 5 years, Larimar Therapeutics' Research & Development had a median value of $10.4 million in 2015 and averaged $10.4 million.
- In the last 5 years, Larimar Therapeutics' Research & Development soared by 21190.84% in 2015 and then plummeted by 9630.79% in 2019.
- Larimar Therapeutics' Research & Development (Quarter) stood at $17.7 million in 2015, then crashed by 58.91% to $7.3 million in 2016, then skyrocketed by 49.98% to $10.9 million in 2017, then increased by 5.0% to $11.5 million in 2018, then crashed by 96.31% to $423000.0 in 2019.
- Its last three reported values are $423000.0 in Q4 2019, $5.3 million for Q3 2019, and $8.6 million during Q2 2019.